Bobby is a current Managing Director at Evercore. After Graduation, Bobby went to UBS in their Mergers & Acquisitions group in New York. Bobby left UBS in 2018 to pursue a career at Evercore. Throughout his time at Evercore, Bobby has had substantial deal experience totaling over $210 billion worth of M&A transactions. Some of his most notable transactions include; Jazz Pharmaceuticals’ $7.2 B transaction with GW Pharmaceuticals, AstraZeneca’s $39 B acquisition of Alexion Pharmaceuticals, and Bristol- Meyers Squibb’s $90 B acquisition of Celgene.

Bobby arrived at Virginia Tech in 2006. Throughout his time at Virginia Tech, Bobby was involved with a variety of groups on campus, including the Boxing Club at Virginia Tech, Varsity Student-Athlete Tutoring, Virginia Tech’s Big Event, and most notably, SEED. While in SEED, Bobby was a member of the Technology Sector. Lastly, Bobby was an R.B.  Pamplin Scholar and graduated from Virginia Tech as Cum Laude in 2010.